Cargando…

Case‐fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta‐analysis

BACKGROUND: Assessment of the case‐fatality rate (CFR) of major bleeding on dual antiplatelet therapy (DAPT) may improve balancing risks and benefits of different durations of DAPT following percutaneous coronary intervention (PCI). OBJECTIVES: To determine the CFR of major bleeding in patients on D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tritschler, Tobias, Patel, Anuj, Kraaijpoel, Noémie, Bhatt, Deepak L., De Luca, Giuseppe, Di Santo, Pietro, Feres, Fausto, Costa, Ricardo A., Hibbert, Benjamin, Isshiki, Takaaki, Le Gal, Grégoire, Castellucci, Lana A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634492/ https://www.ncbi.nlm.nih.gov/pubmed/36349260 http://dx.doi.org/10.1002/rth2.12834

Ejemplares similares

Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
por: Castellucci, Lana A, et al.
Publicado: (2013)

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022)

Novel Antiplatelet Therapies for Atherothrombotic Diseases
por: Majithia, Arjun, et al.
Publicado: (2019)

Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol
por: Khan, Faizan, et al.
Publicado: (2019)

The balloon impasse sign in percutaneous transvenous mitral valvuloplasty
por: Simard, Trevor, et al.
Publicado: (2020)

Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Anticoagulants/antiplatelets: Bleeding: 14 case reports
Publicado: (2020)

Antiplatelet Therapy and Percutaneous Coronary Interventions
por: Davanzo, Rene Hameau, et al.
Publicado: (2021)

Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents
por: Oh, Hyoung-Chul, et al.
Publicado: (2018)

Genetic testing in antiplatelet therapy – not effective for perioperative bleeding
por: Kuliczkowski, Wiktor
Publicado: (2017)

Antiplatelets/enoxaparin-sodium: Major bleeding: case report
Publicado: (2020)

The stent in the high-bleeding risk patient: antiplatelet monotherapy?
por: Capranzano, Piera
Publicado: (2022)

Novel aspects of antiplatelet therapy in cardiovascular disease
por: Gremmel, Thomas, et al.
Publicado: (2018)

Intensity of antiplatelet therapy and percutaneous coronary intervention
por: Aronow, Wilbert S
Publicado: (2009)

Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018)

One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients
por: Kandzari, David E., et al.
Publicado: (2020)

Risk of Postdischarge Bleeding From Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Among US Black and White Adults
por: Heindl, Brittain, et al.
Publicado: (2022)

Dual antiplatelet therapy after percutaneous coronary intervention in patients at high bleeding risk: A systematic review and meta-analysis
por: Han, Yan, et al.
Publicado: (2023)

Dieulafoy’s Lesion of the Duodenum: A Rare and Fatal Cause of Gastrointestinal Bleed
por: Qasim, Abeer, et al.
Publicado: (2023)

Rebuttal From Dr Tritschler et al
por: Tritschler, Tobias, et al.
Publicado: (2022)

POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes
por: Tritschler, Tobias, et al.
Publicado: (2022)

Dual Antiplatelet Therapy and the Severity Risk of Lower Intestinal Bleeding
por: Carlin, Neal, et al.
Publicado: (2017)

Reversing Bleeding Associated With Antiplatelet Use: The Role of Tranexamic Acid
por: Fischer, Kyle, et al.
Publicado: (2020)

Percutaneous Nephrolithotomy in Patients on Chronic Anticoagulant/Antiplatelet Therapy
por: Nerli, R B, et al.
Publicado: (2012)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)

Income and antiplatelet adherence following percutaneous coronary intervention
por: LaRosa, Anna R., et al.
Publicado: (2022)

Aspirin vs Clopidogrel: Antiplatelet Agent of Choice for Those With Recent Bleeding or at Risk for Gastrointestinal Bleed
por: Gosavi, Siddharth, et al.
Publicado: (2023)

In-hospital Bleeding Outcomes of Oral Anticoagulant and Dual Antiplatelet Therapy During Percutaneous Coronary Intervention: An Analysis From the Japanese Nationwide Registry
por: Yashima, Fumiaki, et al.
Publicado: (2021)

Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis
por: Bainey, Kevin R., et al.
Publicado: (2023)

Response
por: Moores, Lisa K., et al.
Publicado: (2022)

Thrombocytopenia with and without Thrombosis Following COVID-19 Vaccination
por: Ge, Melissa, et al.
Publicado: (2021)

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
por: Staudacher, Dawid L., et al.
Publicado: (2016)

Effects of Antiplatelet Agents on Bleeding after Endoscopic Resection of Gastric Tumor
por: Ahn, Ji Yong
Publicado: (2018)

Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
por: Tersalvi, Gregorio, et al.
Publicado: (2020)

Management of Bleeding Events Associated with Antiplatelet Therapy: Evidence, Uncertainties and Pitfalls
por: Godier, Anne, et al.
Publicado: (2020)

The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis
por: Wang, Qi, et al.
Publicado: (2020)

Regulation of Key Antiplatelet Pathways by Bioactive Compounds with Minimal Bleeding Risk
por: Fuentes, Eduardo, et al.
Publicado: (2021)

Incidence of bleeding in patients on different anticoagulants and antiplatelet therapies undergoing thoracentesis
por: Aljundi, Lamia, et al.
Publicado: (2021)

Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia
por: Woodhouse, Lisa J., et al.
Publicado: (2023)

Incorporation of Laboratory Test Biomarkers Into Dual Antiplatelet Therapy Score Improves Prediction of Ischemic and Bleeding Events in Post-percutaneous Coronary Intervention Patients
por: Sun, Chengming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p56rjkoth7pn56916arprjeol5